Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 313 clinical trials
Featured trial
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)

to vehicle cream will be rerandomized (1:1) in a blinded manner to 1 of the 2 active treatment groups (ruxolitinib cream 0.75% or 1.5%).

  • 13 views
  • 11 May, 2022
  • 51 locations
Featured trial
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 compared to placebo, for the treatment of agitation in participants with dementia of the Alzheimer's type.

agitation
dementia
  • 2 views
  • 05 Aug, 2022
  • 77 locations
Featured trial
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer (POD1UM-304)

The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metastatic squamous and nonsquamous non-small cell lung cancer (NSCLC).

  • 0 views
  • 11 Aug, 2022
  • 120 locations
Featured trial
A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial

A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial

  • 2264 views
  • 23 Nov, 2020
  • 22 locations
Featured trial
A multi-center, double-blind, randomized, vehicle-controlled, parallel-group study to compare Perrigo UK FINCO ingenol mebutate topic Gel 0.015% to Leo Pharma Inc. Picato Topical Gel 0.015% (Ingenol Mebutate Topical Gel 0.015%), and both active treatments to a vehicle control in the treatment of actinic keratosis on the head region (face or scalp)

A multi-center, double-blind, randomized, vehicle-controlled, parallel-group study to compare Perrigo UK FINCO ingenol mebutate topic Gel 0.015% to Leo Pharma Inc. Picato Topical Gel 0.015% (Ingenol Mebutate Topical Gel 0.015%), and both active treatments to a vehicle control in the treatment of actinic keratosis on the head region (face or …

  • 106 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A double-blind, randomized, parallel-group vehicle-controlled, multi-center study comparing a generic tazarotene cream, 0.05% to reference listed drug tazorac (tazarotene) cream, 0.05% and both active treatments to a vehicle control in the treatment of plaque psoriasis

A double-blind, randomized, parallel-group vehicle-controlled, multi-center study comparing a generic tazarotene cream, 0.05% to reference listed drug tazorac (tazarotene) cream, 0.05% and both active treatments to a vehicle control in the treatment of plaque psoriasis

  • 186 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Modified Comprehensive Behavioral Intervention for Tics for Children with Tic Disorder, Co-occurring Attention Deficit Hyperactivity Disorder, and Psychosocial Impairment

Modified Comprehensive Behavioral Intervention for Tics for Children with Tic Disorder, Co-occurring Attention Deficit Hyperactivity Disorder, and Psychosocial Impairment

  • 105 views
  • 25 Mar, 2021
  • 1 location
Study of VIB7734 for the Treatment of Moderate to Severely Active SLE (RECAST SLE)

participants. The study duration will be 48 weeks, with a safety follow-up through week 56.There will be 3 parallel arms - 2 active treatment and 1 placebo.

  • 2 views
  • 18 Apr, 2022
  • 71 locations
(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI

arms in the study, one with active treatment and one with an inactive compound (placebo). Treatment is by 1 hour intravenous infusion, for three days. Patients are followed up for 28 days to see if

  • 15 views
  • 29 Jul, 2022
  • 124 locations
Eptinezumab in Participants With Episodic Cluster Headache (ALLEVIATE)

The purpose of this study is to evaluate the efficacy of eptinezumab in participants with episodic Cluster Headache (eCH)

  • 1 views
  • 27 Jul, 2022
  • 104 locations